Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Many patients remain without a diagnosis despite extensive medical evaluation. The Undiagnosed Diseases Network (UDN) was established to apply a multidisciplinary model in the evaluation of the most challenging cases and to identify the biologic characteristics of newly discovered diseases. The UDN, which is funded by the National Institutes of Health, was formed in 2014 as a network of seven clinical sites, two sequencing cores, and a coordinating center. Later, a central biorepository, a metabolomics core, and a model organisms screening center were added. METHODS: We evaluated patients who were referred to the UDN over a period of 20 months. The patients were required to have an undiagnosed condition despite thorough evaluation by a health care provider. We determined the rate of diagnosis among patients who subsequently had a complete evaluation, and we observed the effect of diagnosis on medical care. RESULTS: A total of 1519 patients (53% female) were referred to the UDN, of whom 601 (40%) were accepted for evaluation. Of the accepted patients, 192 (32%) had previously undergone exome sequencing. Symptoms were neurologic in 40% of the applicants, musculoskeletal in 10%, immunologic in 7%, gastrointestinal in 7%, and rheumatologic in 6%. Of the 382 patients who had a complete evaluation, 132 received a diagnosis, yielding a rate of diagnosis of 35%. A total of 15 diagnoses (11%) were made by clinical review alone, and 98 (74%) were made by exome or genome sequencing. Of the diagnoses, 21% led to recommendations regarding changes in therapy, 37% led to changes in diagnostic testing, and 36% led to variant-specific genetic counseling. We defined 31 new syndromes. CONCLUSIONS: The UDN established a diagnosis in 132 of the 382 patients who had a complete evaluation, yielding a rate of diagnosis of 35%. (Funded by the National Institutes of Health Common Fund.).
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease
- Date Crossref
- 29/11/2018
- Éditeur
- Massachusetts Medical Society
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Harvard University pays non établi dans la noticeUniversité ou école supérieure
-
Anna Needs Neuroblastoma Answers pays non établi dans la noticeOrganisation à but non lucratif
-
University of Maryland Brigham and Women’s Hospital (J.L.) pays non établi dans la noticeUniversité ou école supérieure
-
National Institutes of Health Clinical Center pays non établi dans la noticeÉtablissement de santé
-
Baylor College of Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Stanford University pays non établi dans la noticeUniversité ou école supérieure
-
Vanderbilt University pays non établi dans la noticeUniversité ou école supérieure
-
HudsonAlpha Institute for Biotechnology pays non établi dans la noticeOrganisation à but non lucratif
-
Oregon Health & Science University pays non établi dans la noticeUniversité ou école supérieure
-
Brigham and Women's Hospital pays non établi dans la noticeÉtablissement de santé
-
Pacific Northwest National Laboratory pays non établi dans la noticeStructure de recherche
-
University of California pays non établi dans la noticeUniversité ou école supérieure
Harvard University, Anna Needs Neuroblastoma Answers et Brigham and Women’s Hospital (J.L.) — University of Maryland, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.